Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

NCT04274738

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General Hospital Cancer Center Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma

NCT03110562

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Boca Raton Clinical Research (BRCR) Medical Center Plantation, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Kaiser Permanente Hawaii Honolulu, Hawaii, United States
  • McFarland Clinic Ames, Iowa, United States
View all 157 locations
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03859427

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +21 more
Locations
  • Robert A Moss Oncology Fountain Valley, California, United States
  • Rocky Mountain Cancer Centers Denver Midtown Denver, Colorado, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 108 locations
View Trial Details

Related conditions